<DOC>
	<DOCNO>NCT00190099</DOCNO>
	<brief_summary>The major obstacle long- term success percutaneous coronary intervention ( PCI ) restenosis . Restenosis result complex pathophysiological response vascular tissue balloon injury . In pre-stent era , 80 % attribute vascular recoil . However , way mechanical support metallic stent , recoil major reason restenosis . About 80 % In-stent restenosis result intimal hyperplasia . The mechanism Intra-stent restenosis include 4 stage . First stage comprise first 3 day balloon injury , inflammatory reaction severe throughout course . At time , anti-inflammatory drug steroid wuold helpful prevent course restenosis . Until end third week , smooth muscle cell migrate proliferate second third stage , key effort prevent restenosis right inhibition cell cycle . Intravascular radiotherapy ( call Brachytherapy ) stent-based drug elution target upon . Among , rapamycin paclitaxel prove effective animal human experience . The last stage re-epithelization , estrogen could promote process consider effective stage . Stent-based elution corticosteroid , despite feasibility safety , effective anti-proliferation agent ( eg . Rapamycin etc ) . The major reason might patient group coronary artery disease heterogenous one . We believe apply corticosteroid patient elevate inflammatory parameter , i.e . acute coronary syndrome ( ACS ) effect anti-restenosis would obvious . In study , special-designed , phosphorylcholine-coated stent , dexamethasone could readily absorb gradually release locally even 4 week deployment . We expect reduction In-stent restenosis ACS patient method systemic adverse effect steroid ; angiographic follow-up well intra-vascular ultrasound assessment would perform accord pur protocol .</brief_summary>
	<brief_title>Dexamethasone-Eluting Stent Acute Coronary Syndrome Prevent Restenosis</brief_title>
	<detailed_description>The major obstacle long- term success percutaneous coronary intervention ( PCI ) restenosis . Restenosis result complex pathopysiological response vascular tissue balloon injury . In pre-stent era , 80 % attribute vascular recoil . However , way mechanical support metallic stent , recoil major reason restenosis . About 80 % In-stent restenosis result intimal hyperplasia . The mechanism Intra-stent restenosis include 4 stage . First stage comprise first 3 day balloon injury , inflammatory reaction severe throughout course . At time , anti-inflammatory drug steroid would helpful prevent course restenosis . Until end third week , smooth muscle cell migrate proliferate second third stage , key effort prevent restenosis right inhibition cell cycle . Intravascular radiotherapy ( call Brachytherapy ) stent-based drug elution target upon . Among , rapamycin paclitaxel prove effective animal human experience . The last stage re-epithelization , estrogen could promote process consider effective stage . Stent-based elution corticosteroid , despite feasibility safety , effective anti-proliferation agent ( eg . Rapamycin etc ) . The major reason might patient group coronary artery disease heterogenous one . We believe apply corticosteroid patient elevate inflammatory parameter , i.e . acute coronary syndrome ( ACS ) effect anti-restenosis would obvious . In study , special-designed , phosphorylcholine-coated stent , dexamethasone could readily absorb gradually release locally even 4 week deployment . We expect reduction In-stent restenosis ACS patient method systemic adverse effect steroid ; angiographic follow-up well intra-vascular ultrasound assessment would perform accord pur protocol .</detailed_description>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>ACS patient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2004</verification_date>
	<keyword>In-stent restenosis ,</keyword>
	<keyword>Drug elute stent ,</keyword>
	<keyword>dexamethasone ,</keyword>
	<keyword>Acute coronary syndrome</keyword>
</DOC>